Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weijing Sun

Showing results (91-100 of 139) with videos related to

Pageof 14
Sort By:
Journal of Medicinal Food|June 1, 2018
Schisantherin A Improves Learning and Memory of Mice with D-Galactose-Induced Learning and Memory Impairment Through Its Antioxidation and Regulation of p19/p53/p21/Cyclin D1/CDK4/RB Gene ExpressionsCong Liu, Weijing Sun, Ning Li, et al.
BMC Cancer|June 5, 2020
Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: a Meta-analysis and systematic reviewGhulam Rehman Mohyuddin, Muhammad Aziz, Alec Britt, et al.
Journal of Gastrointestinal Oncology|July 25, 2017
Gemcitabine/nab-paclitaxel as second-line therapy following FOLFIRINOX in metastatic/advanced pancreatic cancer-retrospective analysis of responseKhanh T Nguyen, Aparna Kalyan, H Scott Beasley, et al.
British Journal of Clinical Pharmacology|January 11, 2019
Open-label study to evaluate trifluridine/tipiracil safety, tolerability and pharmacokinetics in patients with advanced solid tumours and hepatic impairmentMuhammad Wasif Saif, Lee Rosen, Michelle A Rudek, et al.
Cancer|April 4, 2003
Dose escalation study of tezacitabine in combination with cisplatin in patients with advanced cancerKeith T Flaherty, James P Stevenson, Maryann Gallagher, et al.
Exploration of Targeted Anti-Tumor Therapy|July 17, 2023
Real world outcomes in patients with neuroendocrine tumor receiving peptide receptor radionucleotide therapyStijn Hentzen, Kathan Mehta, Raed Moh'd Taiseer Al-Rajabi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2002
Phase I and pharmacokinetic trial of the proapoptotic sulindac analog CP-461 in patients with advanced cancerWeijing Sun, James P Stevenson, James M Gallo, et al.
Cancer|December 19, 2018
A phase 2 trial of regorafenib as a single agent in patients with chemotherapy-refractory, advanced, and metastatic biliary tract adenocarcinomaWeijing Sun, Anuj Patel, Daniel Normolle, et al.
The Lancet. Oncology|December 3, 2014
Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trialsHans-Joachim Schmoll, Chris Twelves, Weijing Sun, et al.
Plos One|April 3, 2025
Time-restricted feeding reduced blood pressure and improved cardiac structure and function by regulating both circulating and local renin-angiotensin systems in spontaneously hypertensive rat modelXin Yi, Razif Abas, Raja Abdul Wafy Raja Muhammad Rooshdi, et al.
Pageof 14

Showing results (91-100 of 139) with videos related to

Sort By:
Pageof 14
Journal of Medicinal Food|June 1, 2018
Schisantherin A Improves Learning and Memory of Mice with D-Galactose-Induced Learning and Memory Impairment Through Its Antioxidation and Regulation of p19/p53/p21/Cyclin D1/CDK4/RB Gene ExpressionsCong Liu, Weijing Sun, Ning Li, et al.
BMC Cancer|June 5, 2020
Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: a Meta-analysis and systematic reviewGhulam Rehman Mohyuddin, Muhammad Aziz, Alec Britt, et al.
Journal of Gastrointestinal Oncology|July 25, 2017
Gemcitabine/nab-paclitaxel as second-line therapy following FOLFIRINOX in metastatic/advanced pancreatic cancer-retrospective analysis of responseKhanh T Nguyen, Aparna Kalyan, H Scott Beasley, et al.
British Journal of Clinical Pharmacology|January 11, 2019
Open-label study to evaluate trifluridine/tipiracil safety, tolerability and pharmacokinetics in patients with advanced solid tumours and hepatic impairmentMuhammad Wasif Saif, Lee Rosen, Michelle A Rudek, et al.
Cancer|April 4, 2003
Dose escalation study of tezacitabine in combination with cisplatin in patients with advanced cancerKeith T Flaherty, James P Stevenson, Maryann Gallagher, et al.
Exploration of Targeted Anti-Tumor Therapy|July 17, 2023
Real world outcomes in patients with neuroendocrine tumor receiving peptide receptor radionucleotide therapyStijn Hentzen, Kathan Mehta, Raed Moh'd Taiseer Al-Rajabi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2002
Phase I and pharmacokinetic trial of the proapoptotic sulindac analog CP-461 in patients with advanced cancerWeijing Sun, James P Stevenson, James M Gallo, et al.
Cancer|December 19, 2018
A phase 2 trial of regorafenib as a single agent in patients with chemotherapy-refractory, advanced, and metastatic biliary tract adenocarcinomaWeijing Sun, Anuj Patel, Daniel Normolle, et al.
The Lancet. Oncology|December 3, 2014
Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trialsHans-Joachim Schmoll, Chris Twelves, Weijing Sun, et al.
Plos One|April 3, 2025
Time-restricted feeding reduced blood pressure and improved cardiac structure and function by regulating both circulating and local renin-angiotensin systems in spontaneously hypertensive rat modelXin Yi, Razif Abas, Raja Abdul Wafy Raja Muhammad Rooshdi, et al.
Pageof 14